About Vanguard Emerging Markets Select Stock Fund (VMMSX) β Dividend Analysis 2026
This actively managed fund provides exposure primarily to emerging markets outside of the United States at a relatively low cost. Stocks of companies in emerging markets tend to be more volatile than those in developed countries, which could imply the potential for greater long-term returns. Along with this potential, however, comes risks such as currency and political risks. Long-term, risk-tolerant investors who want to diversify their international portfolio may wish to consider this fund.
Is VMMSX a good dividend investment in 2026?
VMMSX offers a 2.30% forward yield with a 50% payout ratio. Strand Safety Score: N/A. The 5-year dividend CAGR of 0% is modest β investors should weigh current income against growth alternatives.
VMMSX DRIP calculator β what's the difference?
With DRIP on a $10,000 investment over 10 years, your VMMSX portfolio grows to $12.6K vs $12.3K without reinvestment. This is the compound interest effect in action.
VMMSX dividend growth history & forecast
VMMSX has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 2.30%.
ETFs do not file income statements or cash flow statements. Their dividend safety depends on the underlying index quality, fund methodology, and holdings composition. Use the Holdings page to analyze individual stocks in this fund.
π VMMSX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold VMMSX.
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― VMMSX Income Goal & Break-Even
Dividend Break-Even
50yr+
Years for dividends to fully repay your VMMSX investment of $28.23/share (πΊπΈ US Taxable (15%) Β· 15.00% tax)
$10K invested Β· 10 Years
Dividends earned (DRIP)
$2.1K
Lost to inflation (2.8% CPI)
β$2.5K
Real purchasing power gain
$-332.04
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in VMMSX for:
Shares needed
43,413
Capital required
$1,225,549
Monthly income
$2,000
Based on current dividend of $0.65/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π VMMSX Dividend Payment Schedule
VMMSX pays quarterly β 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
π°
Apr
May
Jun
π°
Jul
Aug
Sep
π°
Oct
Nov
Dec
π°
10 shares
$1.38 / payment
$5.53 / year after tax
100 shares
$13.82 / payment
$55.28 / year after tax
1,000 shares
$138.21 / payment
$552.84 / year after tax
π VMMSX vs Financial Services Benchmarks
How VMMSX compares to typical Financial Services averages.
Benchmark: Financial Services
Dividend YieldβΌ-0.60% vs sectorBelow avg
VMMSX
2.30%
avg
2.90%
5Y Dividend CAGRβΌ-7.10% vs sectorBelow avg
VMMSX
0.00%
avg
7.10%
Payout RatioβΌ+12.00% vs sectorBelow avg
VMMSX
50.00%
avg
38.00%
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for VMMSX sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ VMMSX Insider Activity
No recent SEC filings reported in the last 90 days.
π About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the VMMSX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β